CAT and major depressive disorder: It is demonstrated that silymarin and silybin improve neurogenesis in the prefrontal cortex and hippocampus by modulating SOD and catalase (CAT) activities, alleviating symptoms of depression and anxiety (Rostamian et al., 2023).